Photo: Istituto Tumori 'Giovanni Paolo II' Bari - IRCCS/ facebook.com
May 11, 2025, 13:58
Domenico Galetta: Interesting and Intense Discussion on the Role of Neoadjuvant vs Perioperative Chemo-Immunotherapy at RomeLung25
Domenico Galetta, Medical oncologist at IRCCS Giovanni Paolo II, shared a post on X:
“Very interesting and intense discussion on the role of neoadjuvant vs perioperative chemo-immunotherapy.
There is still no definitive consensus, many questions remain open, but a new path is now fully achievable.”
More posts featuring RomeLung25
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20